See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
This protocol presents an updated common methodology for estimating COVID-19 vaccine effectiveness (VE) using established health data registries in participating European Union (EU) and European Economic Area (EEA) Member States.
This report presents a description of COVID-19 vaccine coverage in the EU/EEA between 1 August 2024 and 17 January 2025, with some variation in dates between countries.
The 2025 Tuberculosis surveillance and monitoring report shows that children under 15 years of age accounted for 4.3% of those with new and relapsed tuberculosis (TB) in the WHO European Region, representing a worrying 10% surge in paediatric TB for 2023.
Veronica Cristea, Scientific Officer at ECDC, discusses the overall TB situation in the EU/EEA, the impact of COVID-19, challenges in treatment success, and the concerning rise in TB cases among children.
There is currently high respiratory virus activity in the EU/EEA. Both flu and RSV epidemics are still ongoing. Individuals eligible for vaccination are strongly encouraged to get vaccinated. Preventive measures, such as frequent handwashing, maintaining physical distance, avoiding large gatherings, and wearing masks in healthcare settings can help reduce transmission and protect those at high risk of severe illness.
ECDC cooperates with countries in the Western Balkans and Türkiye to improve their infectious disease prevention and control systems and public health workforce to prepare them for their future participation in ECDC’s work.
This report provides an overview of the latest tuberculosis (TB) epidemiological situation and is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control. In 2023, 38 993 cases of TB were reported in 29 European Union and European Economic Area (EU/ EEA) countries, resulting in a notification rate of 8.6 per 100 000 population in the EU/ EEA.
